Support for COVID-19 test development
Actim offers a serological antibody detection ELISA test for detecting recent COVID-19 infection. A highly reliable Actim ELISA SARS-CoV-2 IgG test gives quantitative results in less than two hours with outstanding specificity (98%) and sensitivity (96%).
The test provides R&D and research laboratories an accurate and efficient comparison method for product verifications.
Actim ELISA SARS-CoV-2 IgG test will be one the most reliable tests on the market:
CE-mark of the Actim ELISA SARS-CoV-2 IgG test is expected to be completed in early December 2020, but samples for evaluation purposes are available now.